The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me
It inhibits tyrosinase activity that reduces the concentration of eumelanin, responsible for skin dullness
Building intimacy outside the bedroom can do wonders for improving relationships and emotional well-being
Out-of-pocket costs of Wegovy are around $1,500 per month, while a one-month supply of Ozempic costs a bit less, with an average of $1,100
Always talk to a healthcare provider: We cant emphasize that first point enough its vital to check with a provider before you take something new
VLDL Cholesterol: The Bad Cholesterol VLDL cholesterol is considered one of the bad types of cholesterol because it contributes to the buildup of fatty deposits in the arteries, known as plaque
